Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004969810 | SCV005536099 | uncertain significance | Inborn genetic diseases | 2024-12-04 | criteria provided, single submitter | clinical testing | The c.1063G>A (p.D355N) alteration is located in exon 5 (coding exon 4) of the UMOD gene. This alteration results from a G to A substitution at nucleotide position 1063, causing the aspartic acid (D) at amino acid position 355 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005006608 | SCV005638492 | uncertain significance | Familial juvenile hyperuricemic nephropathy type 1 | 2024-04-02 | criteria provided, single submitter | clinical testing |